Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NC-003: TMC207, PA-824, Pyrazinamide, and Clofazimine in Pulmonary Tuberculosis
NCT01691534Phase 2Completed
- Sponsor
- TB Alliance
- Start
- Oct 2012
- Primary completion
- Apr 2013
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bedaquiline, pretomanid in pulmonary tuberculosis (TB), sponsored by TB Alliance. Started Oct 2012; status: completed.
02
Drugs
bedaquilinepretomanid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT01691534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01691534.